lobbying_activities: 2960290
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2960290 | 66ac7d57-49e9-4c00-99fc-04349c279e10 | Q1 | TIBER CREEK GROUP | 20744 | JAZZ PHARMACEUTICALS | 2023 | first_quarter | MED | Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and Human Services. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2023-04-16T16:34:53-04:00 |